Exogenous pro-angiogenic stimuli cannot prevent physiologic vessel regression

J Surg Res. 2006 Oct;135(2):218-25. doi: 10.1016/j.jss.2006.04.006. Epub 2006 Aug 14.

Abstract

Background: In healing wounds, rising levels of vascular endothelial growth factor (VEGF) induce a period of robust angiogenesis. The levels of pro-angiogenic factors in the wound begin to decline just before a period of vascular regression, suggesting that these mediators are necessary to sustain vessel density. The purpose of this study was to determine if the maintenance of pro-angiogenic stimuli in the wound would prevent physiological vessel regression.

Materials and methods: A standard subcutaneous sponge wound model was modified by the addition of a mini-osmotic pump, allowing manipulation of the wound milieu by the addition of exogenous growth factors. After initial characterization of this model, exogenous VEGF (10 microg/mL), FGF (10 microg/mL), PDGF (10 microg/mL), or VEGF (10 microg/mL) plus FGF (10 microg/mL) were delivered to wounds and blood vessel density analyzed by immunohistochemistry.

Results: VEGF administration resulted in a transient increase in wound vessel density (P < 0.05). None of the pro-angiogenic growth factors (VEGF, FGF, PDGF, VEGF/FGF) were able to prevent vascular regression (P = NS).

Conclusions: These findings suggest that the anti-angiogenic signals that mediate physiological vascular regression in wounds are strongly dominant over pro-angiogenic stimuli during the later phases of wound healing. Clinical manipulation of anti-angiogenic signals in addition to the currently used pro-angiogenic targets may be needed to achieve therapeutic modulation of blood vessel density.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Analysis of Variance
  • Angiogenesis Inducing Agents / pharmacology*
  • Animals
  • Blood Vessels / drug effects*
  • Blood Vessels / growth & development
  • Female
  • Fibroblast Growth Factors / pharmacology
  • Immunohistochemistry
  • Mice
  • Mice, Inbred BALB C
  • Platelet-Derived Growth Factor / pharmacology
  • Vascular Endothelial Growth Factor A / pharmacology
  • Wound Healing / physiology*

Substances

  • Angiogenesis Inducing Agents
  • Platelet-Derived Growth Factor
  • Vascular Endothelial Growth Factor A
  • vascular endothelial growth factor A, mouse
  • Fibroblast Growth Factors